Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Syngene International Limited
  6. News
  7. Summary
    539268   INE398R01022

SYNGENE INTERNATIONAL LIMITED

(539268)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Syngene International Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021

10/20/2021 | 11:58am EST

Syngene International Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 6,102 million compared to INR 5,196 million a year ago. Revenue was INR 6,231 million compared to INR 5,334 million a year ago. Net income was INR 667 million compared to INR 841 million a year ago. Basic earnings per share from continuing operations was INR 1.64 compared to INR 2.12 a year ago. Diluted earnings per share from continuing operations was INR 1.63 compared to INR 2.1 a year ago. For the six months, sales was INR 12,047 million compared to INR 9,412 million a year ago. Revenue was INR 12,299 million compared to INR 9,703 million a year ago. Net income was INR 1,440 million compared to INR 1,421 million a year ago. Basic earnings per share from continuing operations was INR 3.55 compared to INR 3.58 a year ago. Diluted earnings per share from continuing operations was INR 3.53 compared to INR 3.57 a year ago.


© S&P Capital IQ 2021
All news about SYNGENE INTERNATIONAL LIMITED
10/21SYNGENE INTERNATIONAL : Logs 21% Drop in Consolidated Net Profit in Fiscal Q2; Shares Slid..
MT
10/20Syngene International Limited Reports Earnings Results for the Second Quarter and Six M..
CI
07/20SYNGENE INTERNATIONAL : Consolidated Net Profit Climbs in Fiscal Q1
MT
07/20Syngene International Limited Announces Resignation of John M M Shaw from the Board of ..
CI
07/20Syngene International Limited Reports Earnings Results for the First Quarter Ended June..
CI
06/22Syngene International Limited Appoints Dr. Kush Parmar as an Additional Director (Indep..
CI
05/26DYADIC INTERNATIONAL : Syngene to Join Forces for COVID-19 Vaccine Production
MT
05/26SYNGENE INTERNATIONAL : Dyadic announces development of COVID-19 Vaccine in India
AQ
05/26Dyadic International, Inc. Enters into Collaboration with Syngene International Limited
CI
04/28BIOCON : Syngene targets delivering 500,000 vials of remdesivir in India as COVID-19 surge..
RE
More news
Financials
Sales 2022 26 105 M 348 M 348 M
Net income 2022 4 111 M 54,8 M 54,8 M
Net Debt 2022 - - -
P/E ratio 2022 57,1x
Yield 2022 0,08%
Capitalization 233 B 3 106 M 3 113 M
Capi. / Sales 2022 8,94x
Capi. / Sales 2023 7,90x
Nbr of Employees 5 437
Free-Float 28,4%
Chart SYNGENE INTERNATIONAL LIMITED
Duration : Period :
Syngene International Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SYNGENE INTERNATIONAL LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 588,40 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Jonathan Hunt Chief Executive Officer, MD & Executive Director
Sibaji Biswas Chief Financial Officer
Kiran Mazumdar-Shaw Non-Executive Chairman
Mahesh K Bhalgat Chief Operating Officer
Priyadarshini I. Mahapatra Secretary & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
SYNGENE INTERNATIONAL LIMITED-8.01%3 143
MODERNA, INC.237.35%142 893
LONZA GROUP AG30.63%59 859
IQVIA HOLDINGS INC.44.63%49 504
SEAGEN INC.-8.64%29 257
CELLTRION, INC.-42.34%23 827